VIR
Vir Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.39
−0.57%Margins
Gross margin
170.0%
EBITDA margin
-80.6%
EBIT margin
-89.0%
Net margin
-83.0%
FCF margin
-109.3%
-25.6%
Return on equity
-20.7%
Return on assets
-25.1%
Return on invested capital
0.27x
Asset turnover
-$334.9M
Cash from operations
$3.12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026